Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Zhengye Biotechnology Hol...

    NASDAQ: ZYBT · Real-Time Price · USD
    7.36
    1.02 (16.09%)
    At close: Jun 16, 2025, 3:59 PM
    7.18
    -2.45%
    After-hours: Jun 16, 2025, 04:04 PM EDT

    Zhengye Biotechnology Statistics

    Share Statistics

    Zhengye Biotechnology has 47.39M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 47.39M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 62,073

    FTD / Avg. Volume

    n/a
    		 10.34%

    Short Selling Information

    The latest short interest is 182.57K, so 0.39% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 182.57K

    Short % of Shares Out

    n/a
    		 0.39%

    Short % of Float

    n/a
    		 4.12%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    PE Ratio

    n/a
    		 0

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 0

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Zhengye Biotechnology.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.33.

    Current Ratio

    n/a
    		 1.37

    Quick Ratio

    n/a
    		 0.98

    Debt / Equity

    n/a
    		 0.33

    Debt / EBITDA

    n/a
    		 1.25

    Debt / FCF

    n/a
    		 2.46

    Interest Coverage

    n/a
    		 10.17

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $761,334.53

    Profits Per Employee

    n/a
    		 $113,154.68

    Employee Count

    n/a
    		 278

    Asset Turnover

    n/a
    		 0.42

    Inventory Turnover

    n/a
    		 1.4

    Taxes

    Income Tax

    n/a
    		 6.25M

    Effective Tax Rate

    n/a
    		 14.29%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 0, so Zhengye Biotechnology's price volatility has been lower than the market average.

    Beta

    n/a
    		 0

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 8.2

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 48.01

    Average Volume (20 Days)

    n/a
    		 600,261

    Income Statement

    In the last 12 months, Zhengye Biotechnology had revenue of 211.65M and earned 31.46M in profits. Earnings per share was 0.

    Revenue

    n/a
    		 211.65M

    Gross Profit

    n/a
    		 129.85M

    Operating Income

    n/a
    		 44.99M

    Net Income

    n/a
    		 31.46M

    EBITDA

    n/a
    		 72.1M

    EBIT

    n/a
    		 48.19M

    Earnings Per Share (EPS)

    n/a
    		 0
    Full Income Statement

    Balance Sheet

    The company has 15.07M in cash and 89.85M in debt, giving a net cash position of -74.78M.

    Cash & Cash Equivalents

    n/a
    		 15.07M

    Total Debt

    n/a
    		 89.85M

    Net Cash

    n/a
    		 -74.78M

    Retained Earnings

    n/a
    		 38.38M

    Total Assets

    n/a
    		 n/a

    Working Capital

    n/a
    		 n/a
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 48.18M and capital expenditures -11.6M, giving a free cash flow of 36.58M.

    Operating Cash Flow

    n/a
    		 48.18M

    Capital Expenditures

    n/a
    		 -11.6M

    Free Cash Flow

    n/a
    		 36.58M

    FCF Per Share

    n/a
    		 0
    Full Cash Flow Statement

    Margins

    Gross margin is 61.35%, with operating and profit margins of 21.25% and 14.86%.

    Gross Margin

    n/a
    		 61.35%

    Operating Margin

    n/a
    		 21.25%

    Pretax Margin

    n/a
    		 20.68%

    Profit Margin

    n/a
    		 14.86%

    EBITDA Margin

    n/a
    		 34.06%

    EBIT Margin

    n/a
    		 21.25%

    FCF Margin

    n/a
    		 17.29%

    Dividends & Yields

    ZYBT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ZYBT.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 n/a

    Piotroski F-Score

    n/a
    		 n/a

    Add to Watchlist